BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 17633224)

  • 1. [Roles of 20-HETE on physiologic and pathologic regulation in organism].
    Zhang D; Huo HL; Zhang YN; Zeng QH
    Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):120-4. PubMed ID: 17633224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium].
    Li H; Zhu Y
    Sheng Li Ke Xue Jin Zhan; 2013 Feb; 44(1):1-5. PubMed ID: 23671992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system.
    Miyata N; Roman RJ
    J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
    Powell PK; Wolf I; Jin R; Lasker JM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-450 metabolites of arachidonic acid in the control of cardiovascular function.
    Roman RJ
    Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 20-HETE in neovascularization.
    Chen L; Ackerman R; Guo AM
    Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):63-8. PubMed ID: 22227460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension.
    Pat Kunert M; Drenjancević I
    Med Glas (Zenica); 2011 Aug; 8(2):170-80. PubMed ID: 21849935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The roles of intrarenal 20-hydroxyeicosatetraenoic and epoxyeicosatrienoic acids in the regulation of renal function in hypertensive Ren-2 transgenic rats.
    Certíková Chábová V; Kramer HJ; Vanecková I; Thumová M; Skaroupková P; Tesar V; Falck JR; Imig JD; Cervenka L
    Kidney Blood Press Res; 2007; 30(5):335-46. PubMed ID: 17785988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conflicting roles of 20-HETE in hypertension and renal end organ damage.
    Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F
    Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension.
    Sarkis A; Lopez B; Roman RJ
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):205-14. PubMed ID: 15202615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.
    Fan F; Ge Y; Lv W; Elliott MR; Muroya Y; Hirata T; Booz GW; Roman RJ
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1427-63. PubMed ID: 27100515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. omega-Hydroxylation of 15-hydroxyeicosatetraenoic acid by lung microsomes from pregnant rabbits.
    Okita RT; Soberman RJ; Bergholte JM; Masters BS; Hayes R; Murphy RC
    Mol Pharmacol; 1987 Nov; 32(5):706-9. PubMed ID: 3683367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-HETE contributes to myogenic activation of skeletal muscle resistance arteries in Brown Norway and Sprague-Dawley rats.
    Frisbee JC; Roman RJ; Falck JR; Krishna UM; Lombard JH
    Microcirculation; 2001 Feb; 8(1):45-55. PubMed ID: 11296852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat.
    Ma J; Liang S; Wang Z; Zhang L; Jiang J; Zheng J; Yu L; Zheng X; Wang R; Zhu D
    J Cell Physiol; 2010 Jan; 222(1):82-94. PubMed ID: 19746421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow.
    Harder DR; Narayanan J; Gebremedhin D
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1557-65. PubMed ID: 21257913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid.
    Garcia V; Schwartzman ML
    Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):74-82. PubMed ID: 27906746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development.
    Moreno JJ
    Biochem Pharmacol; 2009 Jan; 77(1):1-10. PubMed ID: 18761324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of preglomerular microvascular 20-hydroxyeicosatetraenoic acid levels by salt depletion.
    Carroll MA; Kemp R; Cheng MK; McGiff JC
    Med Sci Monit; 2001; 7(4):567-72. PubMed ID: 11433178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 20-HETE in the regulation of vascular and cardiac function.
    Rocic P; Schwartzman ML
    Pharmacol Ther; 2018 Dec; 192():74-87. PubMed ID: 30048707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats.
    Huang H; Zhou Y; Raju VT; Du J; Chang HH; Wang CY; Brands MW; Falck JR; Wang MH
    Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1116-22. PubMed ID: 15998843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.